SUBSCRIBE
SUBSCRIBE
News   Business

OncoMethylome Sciences S.A. Loses Partner, Refocuses Business

November 5, 2009 | 
1 min read

Bookmark and Share

Reuters -- Belgian biotech company OncoMethylome unveiled plans on Thursday to refocus its cancer diagnosis business and revealed it had lost a partner, pulling down its shares down to a six-month low.

Alliances
MORE ON THIS TOPIC
Large yellow signboard on metal frame with the word IPO. Clear sky in the background. Concept of share trading on stock market, capital investment, currency exchange
IPO
Chinese Biotech Ascentage Aims For $134M IPO
January 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Business
Trump Takes Over, Wegovy Still Trails Zepbound and BioSpace Recaps JPM
January 22, 2025
 · 
1 min read
 · 
Heather McKenzie
Pictured: Facade of Moderna's building in Massachusetts
Vaccines
Moderna Nabs Another $590M from HHS for mRNA-Based Bird Flu Vaccines
January 21, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Job Trends
BioSpace Showcases Life Sciences Hubs in 2025 Hotbed Maps
January 21, 2025
 · 
1 min read
 · 
Chantal Dresner